Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 3/4/2024
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo.
PLOS One
Volume: 10
Date: 10 2012
journals.plos.org/plosone/
Toll-like receptor 4 limits transmission of Bordetella bronchiseptica.
PLOS One
Volume: 1
Date: 01 2014
journals.plos.org/plosone/
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.
Infection & Immunity
Volume: 82
Date: 02 2014
iai.asm.org/
Resident microbiota affect Bordetella pertussis infectious dose and host specificity.
Journal of Infectious Disease
Volume: 209
Date: 03 2014
jid.oxfordjournals.org/
Different effects of whole-cell and acellular vaccines on Bordetella transmission.
Journal of Infectious Disease
Volume: 209
Date: 06 2014
jid.oxfordjournals.org/
Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection.
PLOS One
Volume: 10
Date: 10 2015
journals.plos.org/plosone/
Targeted Physical Therapy Combined with Spasticity Management Changes Motor Development Trajectory for a 2-Year-Old with Cerebral Palsy
Journal of Personalized Medicine
Volume: 3
Date: 02 2021
https://pubmed.ncbi.nlm.nih.gov/33673573/
Effects of stochastic resonance stimulation on manual function in children with hemiplegic cerebral palsy: A pilot clinical trial
PM&R Journal
Volume: 3
Date: 03 2023
https://pubmed.ncbi.nlm.nih.gov/35187840/